摘要
目的针对患有支气管哮喘的患者,通过采用孟鲁司特联合吸入沙美特罗替卡松治疗以后,对其联合治疗的效果进行分析。方法在2015年10月至2018年10月,在本院随机选取80例患有支气管哮喘的患者,将其分为对比组(n=40)和观察组(n=40),分别对其进行沙美特罗替卡松吸入治疗和孟鲁司特联合吸入沙美特罗替卡松治疗,分析两组患者的治疗效率和不良反应发生率。结果本次研究中,观察组患者的治疗效率、不良反应发生率均要优于对比组(P<0.05)。结论针对患有支气管哮喘的患者,通过采用孟鲁司特联合吸入沙美特罗替卡松治疗以后,能够有效改善患者的支气管哮喘症状,使患者的病情得到有效控制,降低患者在治疗过程中的不良反应。
Objective To analyze the effect of Montelukast Combined with salmeterol/fluticasone inhalation on patients with bronchial asthma. Methods From October 2015 to October 2018, 80 patients with bronchial asthma were randomly selected and divided into control group (n=40) and observation group (n=40). Salmeterol and montelukast combined inhalation of salmeterol and fluticasone were administered respectively. The treatment efficiency and incidence of adverse reactions of the two groups were analyzed. Results In this study, the treatment efficiency and the incidence of adverse reactions in the observation group were better than those in the control group (P<0.05). Conclusion For patients with bronchial asthma, Montelukast Combined with inhalation of salmeterol and fluticasone can effectively improve the symptoms of bronchial asthma, effectively control the condition of patients, and reduce the adverse reactions of patients in the course of treatment.
作者
谭金华
TAN Jin-hua(The First Poverty-stricken Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830017)
出处
《智慧健康》
2019年第20期173-174,共2页
Smart Healthcare
关键词
支气管哮喘
孟鲁司特
沙美特罗替卡松
联合治疗
雾化吸入
Bronchial asthma
Montelukast
Salmeterol and fluticasone
Combination therapy
Aerosol inhalation
